← All trials
NCT04780061
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 12, 2021
- Primary completion
- Jan 31, 2022
- Completion date
- Mar 31, 2022
- First posted
- Mar 3, 2021
- Last posted
- Jul 21, 2021
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The Canadian College of Naturopathic MedicineLead sponsor
- The Canadian College of Naturopathic MedicineOverall official - principal investigator
- University of OttawaOverall official - principal investigator
- University of OttawaCollaborator
- Vitazan ProfessionalCollaborator
- New Roots HerbalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.